# Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome

> **NCT00997750** · PHASE4 · COMPLETED · sponsor: **Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation** · enrollment: 85 (actual)

## Conditions studied

- Acute Coronary Syndrome

## Interventions

- **DRUG:** Lornoxicam

## Key facts

- **NCT ID:** NCT00997750
- **Lead sponsor:** Central Clinical Hospital w/Outpatient Health Center of Business Administration for the President of Russian Federation
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-03
- **Primary completion:** 2008-12
- **Final completion:** 2009-06
- **Target enrollment:** 85 (ACTUAL)
- **Last updated:** 2009-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00997750

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00997750, "Efficacy and Safety of Lornoxicam in Patients With Acute Coronary Syndrome". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT00997750. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*